Zhao, Shibin http://orcid.org/0000-0002-4878-3302
Adamiak, Justyna W.
Bonifay, Vincent http://orcid.org/0000-0003-4341-6981
Mehla, Jitender http://orcid.org/0000-0002-7829-557X
Zgurskaya, Helen I. http://orcid.org/0000-0001-8929-4727
Tan, Derek S. http://orcid.org/0000-0002-7956-9659
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01 AI136795, R01 AI136799, R01 AI136795, R01 GM100477, R01 AI118224, P30 CA008748)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 17 July 2020
Accepted: 11 September 2020
First Online: 16 November 2020
Competing interests
: Merck is a collaborating institution on the SPEAR-GN project and has provided in-kind support to the labs of D.S.T. and H.I.Z. D.S.T. serves on the External Advisory Board of the Institute for Research in Biomedicine, Barcelona; is a shareholder and has been a paid consultant and speaker for Merck; and has been a paid consultant or speaker for Eli Lilly, Elsevier, Emerson Collective, and Venenum Biosciences. H.I.Z. has been a paid speaker for Genentech and Novartis Research Institutes.